The human complement component, C5a, binds two different seven transmembrane receptors termed 21 as C5aR1 and C5aR2. C5aR1 is a prototypical G protein-coupled receptor that couples to Gαi sub-family 22 of heterotrimeric G proteins and β-arrestins (βarr) following C5a stimulation. Peptide fragments derived 23 from the carboxyl-terminus of C5a can still interact with the receptor, albeit with lower affinity, and can 24 act as agonists or antagonists. However, whether such fragments might display ligand bias at C5aR1 25 remains unexplored. Here, we compare C5a and a modified C-terminal fragment of C5a, C5a pep , in terms 26 of G protein coupling, βarr recruitment, endocytosis and ERK1/2 MAP kinase activation at the human 27
Introduction 42
The complement peptide C5a, a potent chemotactic agent and an anaphylatoxin, is one of the most 43 critical components of the human complement system (1). C5a is a 74 amino acid long peptide that is 44 generated upon the enzymatic cleavage of complement component C5 by C5-converatse. Abnormal 45 levels of C5a and subsequent signaling triggered by it are crucial in a range of inflammatory disorders 46 including sepsis, rheumatoid arthritis and psoriasis (1, 2) . C5a exerts its effects via two seven 47
C5a with respect to transducer-coupling, functional outcomes and cellular responses. In particular, we 65 measure the ability of C5a and C5a pep to elicit Gαi-coupling, βarr recruitment and trafficking, receptor 66 endocytosis, ERK1/2 MAP kinase activation, IL-6 release and neutrophil migration. We identify a 67 significant bias in transducer-coupling, functional outcomes (i.e. endocytosis vs. ERK1/2 activation) and 68 cellular responses (IL-6 release vs. neutrophil migration) between the two ligands which paves the way 69 for subsequent characterization of physiological outcomes arising from biased signaling at C5aR1. 70
Results and discussion 71
C5a pep is a full-agonist for Gαi-coupling. Although C5a pep exhibits the highest binding affinity for C5aR1 72 amongst the peptides derived from, and modified based on, the carboxyl-terminus of C5a, its binding 73 affinity for C5aR1 is still significantly lower than C5a (~70nM for C5a pep and ~1nM for C5a) (7) . We first 74 measured the ability of C5a pep to trigger Gαi-coupling to C5aR1 in HEK-293 cells using the GloSensor 75 assay (8). Cells were stimulated with Forskolin to generate cAMP followed by incubation with various 76 doses of C5a and C5a pep . We observed that both, C5a and C5a pep inhibited cAMP level to a similar extent 77 at saturating concentrations ( Figure 1C) and with a similar time-kinetics ( Figure S1 ). As expected, based 78 on their binding affinities for the receptor, C5a pep was approximately 100 fold less potent in cAMP 79 inhibition compared to C5a (IC 50 ~ 0.26 nM for C5a and IC 50 ~ 16 nM for C5a pep ). We also measured the 80 efficacy of C5a pep in C5aR1 expressing CHO cells using the LANCE cAMP assay (9) and observed a pattern 81 of efficacy and potency very similar to that in HEK-293 cells ( Figure 1D ). 82
C5a pep is a partial-agonist for βarr recruitment. Upon C5a stimulation, C5aR1 undergoes 83 phosphorylation and recruits βarrs which is important for receptor desensitization and internalization 84 (10). Thus, we next measured the ability of C5a pep to induce βarr coupling using a standard co-85 immunoprecipitation assay. There are two isoforms of βarrs known as βarr1 and 2 which exhibit a 86 significant functional divergence despite a high-level of sequence and structural similarity (11). We 87 expressed either βarr1 or βarr2 with FLAG tagged C5aR1 in HEK-293 cells and then measured their 88 interaction upon ligand stimulation. As presented in Figure 2A , we observed a robust recruitment of 89 both isoforms of βarrs upon stimulation of cells with C5a. Interestingly, the levels of βarr recruitment 90 induced by C5a pep were significantly lower compared to C5a, even at saturating ligand concentrations. As 91 a control, we stimulated the cells with W54011, an antagonist of C5aR1 (12), and expectedly, it did not 92 elicit any significant levels of βarr recruitment. In order to probe if there may be a temporal difference in 93 C5aR1-βarr interaction pattern for C5a vs. C5a pep , we further carried out a time-course experiment for 94 βarr recruitment. Still however, C5a pep -induced βarr recruitment was significantly lower than C5a (Figure  95 2B). Taken together with cAMP data presented above, these findings suggest that C5a pep is biased 96 towards Gαi-coupling over βarr recruitment as revealed by correlation plots using maximal responses in 97 the two transducer-coupling assays ( Figure 2C ). 98
As mentioned earlier, C5a interacts with two 7TMRs, C5aR1 and C5aR2. Of these, C5aR2 (also 99 known as C5L2) does not exhibit any detectable G-protein coupling although it robustly recruits βarrs 100 upon agonist-stimulation (9, 13, 14) . We observed that C5a pep acts as a partial agonist for βarr2 101 recruitment, similar to C5aR1 ( Figure S2 ). This finding suggests that the structural determinants of βarr 102 recruitment in C5aR1 and C5aR2 are conserved while there must be a significant divergence at the level 103 receptor conformation which dictates G-protein coupling. 104
C5a pep triggers slower endosomal trafficking of βarrs. βarrs are normally distributed in the cytoplasm 105 and upon agonist-stimulation, they traffic to the membrane and interact with the receptors (15). 106
Subsequently, upon prolonged agonist-stimulation, βarrs either dissociate from the receptor (class A 107 pattern of βarr recruitment) or co-internalized with activated receptors in endosomal vesicles (class B 108 pattern of βarr recruitment) (15). In order to probe whether C5a pep might differ from C5a with respect to 109 βarr trafficking patterns, we co-expressed C5aR1 with either βarr1-YFP or βarr2-YFP and visualized the 110 trafficking of βarrs using confocal microscopy. We observed that C5a pep was capable of promoting 111 surface translocation of βarrs at similar levels as C5a during the early phase of agonist-stimulation 112 ( Figure 3 , second panels). However, we observed that C5a pep was significantly slower in promoting the 113 appearance of βarrs in endosomal punctae and vesicles compared to C5a (Figure 3 , third panels) 114 although ultimately it did induce robust endosomal localization of βarrs (Figure 3 , fourth panels). 115
C5a pep exhibits bias between ERK1/2 MAP kinase activation and receptor endocytosis. In order to 116 probe whether bias in transducer coupling may translate into differential functional outcomes, we next 117 measured the ability of C5a pep to induce receptor endocytosis and ERK1/2 MAP kinase activation in HEK-118 293 cells. In agreement with our data on βarr recruitment and trafficking presented earlier in Figures 2 119 and 3, we observed a significantly lower levels of receptor endocytosis induced by C5a pep in comparison 120 to C5a ( Figure 4A ). This observation hints that βarrs may play a crucial role in endocytosis of C5aR1 and 121 therefore, weaker βarr recruitment by C5a pep translates into lower endocytosis. Interestingly however, 122
C5a pep was as efficacious as C5a in stimulating phosphorylation of ERK1/2 MAP kinase in 123 at least at the time-points that were tested in this experiment ( Figure 4B -C). Thus, correlation of 124 maximal levels of endocytosis triggered by C5a and C5a pep with the ERK1/2 phosphorylation reveals a 125 bias of C5a pep in these two functional responses ( Figure 4D ). 126 C5a pep exhibits βarr isoform bias at a chimeric C5aR1. The interaction of βarrs with GPCRs is a biphasic 127 process, which involves the receptor-tail (i.e. phosphorylated carboxyl-terminus) and the receptor-core 128 (cytoplasmic surface of the transmembrane bundle) (16). In addition to the fully-engaged complexes 129 involving both the tail and the core interaction, receptor-βarr complexes engaged only through receptor 130 tail are functionally competent in terms of mediating receptor endocytosis and signaling (17) (18) (19) . Based 131 on the stability of their interaction with βarrs, GPCRs are categorized as class A and B which represent 132 transient and stable interactions, respectively (15). Receptors having clusters of phosphorylatable 133 residues in their carboxyl-terminus (such as the vasopressin receptor, V2R) typically interact stably with 134 βarrs. As C5aR1 does not harbor such clusters, we generated a chimeric C5aR1 where we grafted the 135 carboxyl-terminus of the V2R on C5aR1, and refer to this construct as C5a-V2R ( Figure 5A ). We first 136 measured the cAMP response of C5aV2R upon stimulation with C5a and C5a pep , and observed a similar 137 efficacy and potency profile as for the wild-type C5aR1 ( Figure 5B ). Interestingly however, we observed 138 an equal recruitment of βarr1 by C5a pep and C5a with C5a-V2R ( Figure 5C ). On the other hand, βarr2 139 recruitment induced by C5a pep was still significantly weaker than C5a ( Figure 5D ). This resulted in a bias 140 at the level of βarr isoform recruitment for the chimeric receptor as evident in the correlation plot 141 ( Figure 5E ). 142
Our observation of βarr isoform preference for the chimeric receptor is important because 143 several high-throughput screening assays, for example, Tango and enzyme-complementation, utilize 144 chimeric GPCRs with V2R tail. This may result in miscalculation of ligand-bias and therefore, our data 145 suggest that the patterns observed using chimeric receptors should be reanalyzed using wild-type 146
receptors. 147
C5a pep elicits biased cellular responses. C5aR1 is endogenously expressed at high levels in macrophages 148 and neutrophils, where it modulates multiple inflammatory responses (3). Stimulation of C5aR1 in 149 human macrophages reduces LPS-induced release of IL-6 (2), whereas neutrophil C5aR1 activation 150 induces rapid chemotaxis (3). To assess whether C5a pep might exhibit a bias at the level of these cellular 151 responses, we utilized HMDMs and PMNs to measure IL-6 release and migration, respectively. First, we 152 measured Ca ++ mobilization in HMDMs upon stimulation by C5a and C5a pep and observed, once again, a 153 full-agonist profile of C5a pep ( Figure 6A and S3 ). In addition, the inhibition of LPS-induced IL-6 release in 154
HMDMs was also comparable for both C5a and C5a pep ( Figure 6B ). Notably however, we observed that 155 C5a pep displayed a significantly blunted response in neutrophil migration compared to C5a even at 156 saturating doses ( Figure 6C ). These observations therefore reveal a bias at the level of cellular responses 157 exhibited by C5a pep as obvious in the correlation plot ( Figure 6D ). These findings suggest that the bias 158 displayed by C5a pep at the level of transducer-coupling and functional responses measured in HEK-293 159 cells is preserved and translated into a cellular response bias in primary cells at the endogenous level of 160 receptor. 161
Interestingly, C5a pep stimulation resulted in only a sub-maximal phosphorylation of ERK1/2 in 162 HMDMs compared to C5a ( Figure S4 ). This is in contrast with our observation in HEK-293 cells 163 mentioned above where C5a pep stimulates ERK1/2 phosphorylation at levels similar to C5a ( Figure 4B -C). 164 This is particularly interesting considering that C5a pep behaves as full-agonist in Ca ++ mobilization 165 experiment in HMDMs. There is growing evidence for context-specific effector-coupling and functional 166 responses downstream of several GPCRs (20,21). These emerging findings have refined our current 167 understanding of biased signaling by providing substantial evidence of additional levels of complexities 168 in GPCR signaling. Our data with C5a pep , especially in the context of ERK1/2 activation in HMDMs, further 169 adds to this important paradigm of biased GPCR signaling. 170
It is important to mention here that chemokines, like complement C5a, also interact with their 171 cognate GPCRs through a biphasic mechanism. Thus, it is tempting to speculate that fragments derived 172 from the C-terminus of chemokines may also exhibit biased signaling through their receptors. Our 173 findings also suggest that a more comprehensive analysis of C5a fragments might yield βarr-biased 174 ligands at C5aR1. Although crystal structures of C5aR1 bound to small molecule antagonists have been 175 determined recently (22,23), C5a-bound structure is still not available. High-resolution structure details 176 of C5a-bound C5aR1 in future may provide structural insights into differential engagement of C5a pep 177 compared to C5a and how these differential interactions in the ligand-binding pocket yield transducer-178 coupling bias. 179
In summary, we discover C5a pep as a biased C5aR1 agonist at the levels of transducer-coupling, 180 functional outcomes and cellular responses. Going forward, an interesting avenue might be to evaluate 181 the physiological responses elicited by C5a pep in-vivo. Given that C5a attenuates LPS-mediated cytokine 182 production from macrophages ((24) (Fig 6) , a biased ligand such as C5a pep which retains this beneficial 183 activity, whilst diminishing the more pro-inflammatory activities of neutrophil migration, may be a novel 184 therapeutic approach for inflammatory disorders. Furthermore, as we have demonstrated the 185 recruitment of both isoforms of βarr to C5aR1, it would be interesting to evaluate the shared and 186 distinct roles of these βarr in regulation and signaling of C5aR1. It is also notable that the second 187 receptor activated by C5a (C5aR2), does not exhibit any detectable G protein coupling but displays 188 robust βarr recruitment (13). Thus, C5aR2 may represent a natural example of a βarr-biased receptor 189 making it an attractive target to further investigate specific role of βarrs in C5a mediate signaling. The following cell lines were cultured as previously described (25). Chinese hamster ovary cells 206 stably expressing the human C5aR1 (CHO-C5aR1) were maintained in Ham's F12 medium containing 207 10% foetal bovine serum (FBS), 100 U/ml penicillin, 100 μg/ml streptomycin and 400 μg/ml G418 208 (Invivogen). Human embryonic kidney-293 (HEK293) cells were maintained in DMEM medium containing 209 10% FBS, 100 IU/ml penicillin and 100 μg/ml streptomycin. To ensure the consistency of cell function, 210 cell morphology was continually monitored and neither cell line was used beyond passage twenty. 211
To generate human monocyte-derived macrophages (HMDM), human buffy coat blood from 212 anonymous healthy donors was obtained through the Australian Red Cross Blood Service. Human CD14+ 213 monocytes were isolated from blood using Lymphoprep density centrifugation (STEMCELL) followed by 214 CD14+ MACS magnetic bead separation (Miltenyi Biotec). The isolated monocytes were differentiated 215 for 7 days in IMDM supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin and 15 216 ng/ml recombinant human macrophage colony stimulating factor (hM-CSF) (Peprotech) on 10 mm 217 square dishes (Sterilin). Non-adherent cells were removed by washing with DPBS and the adherent 218 differentiated HMDMs were harvested by gentle scraping. 219
Human peripheral blood neutrophils (hPMN) were obtained from venous whole blood (20 ml) 220 collected from healthy volunteers under informed consent. Samples were collected using venepuncture 221 into BD K2EDTA Vacutainer® blood collection tubes and processed within 5 hours. For neutrophil 222 isolation, the anticoagulated blood was firstly layered over a Lymphoprep (STEMCELL) density gradient 223 and centrifuged (800×g, 30 min, 22℃). The cell pellet in the densest layer of the gradient, containing a 224 mixture of hPMN and erythrocytes was collected. The residual erythrocytes were removed using 225 hypotonic lysis. Isolated neutrophils were counted and resuspended in a HBSS-based migration buffer 226 (containing calcium and magnesium, supplemented with 20 mM HEPES and 0.5 % BSA) at a desired 227 concentration. Cell viability was ≥ 92 % as assessed by Trypan blue exclusion on a Bio-Rad TC20™ 228 automated cell counter. 229
Preparation of C5aR1 expressing stable HEK-293 cell line: 50-60% confluent HEK293 cells were 230 transfected with 7μg FLAG tagged C5aR1 DNA complexed with 21μg PEI (polyethylenimine). Next day, 231 stable selection was started with optimal dose of G418 along with untransfected cells kept as negative 232 control. After completion of stable selection, clonal population was prepared by limited dilution 233 method. Highest expressing clones were propagated further and kept under G418 selection throughout 234 the course of experiments. Surface exressionof C5aR1 was measured using a previously described whole 235 cell surface ELISA protocol (26). 236 ERK1/2 phosphorylation assay: Agonist-induced ERK1/2 phosphorylation was measured primarily using 237 a previously described Western blotting based protocol (27) . C5aR1 expressing stable cell lines were 238 seeded into 6-well plate at a density of 1 million cells per well. Cells were serum starved for 12 hour 239 followed by stimulation with 1μM of C5a and 10μM of C5a pep respectively at selected time points. After 240 the completion of time course, media was aspirated and cells were lysed in 100μl 2x SDS dye per well. 241
Cells were heated at 95:C for 15 minute followed by centrifugation at 15000 rpm for 10 minute. 10uL of 242 lysate was loaded per well and separated in SDS-PAGE followed by western blotting. Blots were blocked 243 in 5% BSA (in TBST) for 1 hour and incubated overnight with rabbit phospho ERK (cat #9101/CST) 244 primary antibody at 1:5000 dilution. Blots were washed thrice with TBST for 10 minute each and 245 incubated with anti-rabbit HRP-coupled secondary antibody (1:10000, cat#A00098/Genscript) for 1 246 hour. Blots were washed again with TBST for three times and developed with promega ECL solution on 247 chemidoc (BioRad). Blots were stripped with low pH stripping buffer and then re-probed for total ERK 248 using rabbit total ERK (cat#9102/CST) primary antibody at 1:5000 dilution. 249
The ligand-induced phospho-ERK1/2 signaling was assessed using the AlphaLISA Surefire Ultra p-250 ERK1/2 (Thr202/Tyr204) kit (PerkinElmer) following the manufacturer's protocol. Briefly, HMDMs were 251 seeded (50,000/well) in tissue culture-treated 96-well plates (Corning) for 24 hours and serum-starved 252 overnight. All ligand dilutions were prepared in serum-free medium (SFM) containing 0.1% BSA. For 253 stimulation, cells were incubated with respective ligands for 10 min at room temperature and then 254 immediately lysed using AlphaLISA lysis buffer on a microplate shaker (450 rpm, 10 min). For the 255 detection of phospho-ERK1/2 content, cell lysate (5 μl/well) was transferred to a 384-well ProxiPlate 256 (PerkinElmer) and added to the donor and acceptor reaction mix (2.5 μl/ well, respectively) with 2-hour 257 incubation at room temperature in the dark. On a Tecan Spark 20M, following laser irradiation of donor 258 beads at 680 nm, the chemiluminescence of acceptor beads at 615 nm was recorded. 259
Receptor Internalization Assay: 50-60% confluent HEK293 cells were transfected with 3.5μg of FLAG-260 tagged C5aR1 DNA by polyethylenimine method of transfection at DNA:PEI ratio of 1:3. 24 hour post-261 transfection, 0.15million cells per well were seeded in 24-well plate (pre-coated with 0.01% Poly-D-262 Lysine). After 24 hour, cells were serum starved for 6hour followed by stimulation with 1μM of C5a and 263 10μM C5a pep respectively for selected time points. After stimulation, cells were washed once with ice-264 cold 1XTBS. Cells were then fixed with 4% (w/v) PFA on ice for 20min and washed thrice with TBS to 265 remove PFA. Blocking was done with 1%BSA prepared in 1XTBS for 1.5 hour. This was followed by 266 incubation of cells with HRP-conjugated anti-FLAG M2 antibody (Sigma) at a dilution of 1:2000 prepared 267 in 1% BSA+1XTBS for 1.5 hour. Afterwards, cells were washed thrice with 1% BSA+1XTBS. Surface (HBSS/Gibco) and 20mM HEPES pH 7.4. Cells were then seeded in a 96-well plate at a density of 0.4 281 million cells per well and kept at 37:C for 1.5 hour in the CO 2 incubator followed by incubation at room 282 temperature for 30 minute. Basal reading was read on luminescence mode of multi-plate reader (Victor 283 X4) and cycles were adjusted until basal values were stabilized. Cells were then incubated with 1uM 284 forskolin and readings were recorded until maximum luminescence values were obtained. This was 285 followed by stimulation of cells with specified concentrations of C5a and C5a pep and values were 286 recorded for 1 hour. Data was normalized with respect to minimal stimulation dose of ligand after basal 287
correction. 288
Cross-linking and Co-immunoprecipitation (CoIP): 50-60% confluent HEK293 cells were co-transfected 289 with C5aR1 and βarr1/ βarr2 plasmids by PEI (as mentioned earlier). 48 hour post-transfection, cells 290 were serum starved for 6 hours and stimulated with respective doses of C5a/C5a Pep , harvested and 291 proceeded for cross-linking experiment. Cells were lysed by dounce homogenization in 20mM HEPES 292 pH7.4, 100mM NaCl, 1X phosphatase inhibitor cocktail (Roche), 2mM benzamidine hydrochloride and 293 1mM PMSF. This was followed by addition of 1mM dithiobis(succinimidyl-propionate) from a freshly 294 prepared 100mM stock in DMSO. Lysate was tumbled at room temperature for 40 minute and reaction 295 was quenched by adding 1M Tris pH 8.5. Lysates were solublized in 1%(v/v) MNG for 1 hour at room 296 temperature followed by centrifugation at 15000 rpm for 15min. Cleared supernatant was transferred 297 to a separate tube already containing pre-equilibrated M1-FLAG beads supplemented with 2mM CaCl 2 . 298
Solution was tumbled for 2hour at 4:C and washed alternately with low salt buffer(20mM HEPES pH 7.4, 299
150mM NaCl, 0.01% MNG, 2mM CaCl 2 ) and high salt buffer(20mM HEPES pH7.4, 350mM NaCl, 0.01% 300 MNG, 2mM CaCl 2 ) respectively. The bound proteins were eluted in FLAG-elution buffer containing 301 20mM HEPES pH 7.4, 150mM NaCl, 2mM EDTA, 0.01% MNG and 250ug/mL FLAG peptide. Co-302 immunoprecipitated βarr was detected by western blotting using rabbit anti-βarr mAb (1:5000, CST Cat# 303 D24H9). Blots were stripped and reprobed for receptor with HRP-conjugated anti-FLAG M2 antibody 304
(1:5000). Blots were developed on Chemidoc (BioRad) and quantified using ImageLab software (BioRad). 305
BRET assay for measuring the interaction of βarr2 with C5aR2: C5a-mediated βarr2 recruitment to 306 C5aR2 was measured using bioluminescent resonance energy transfer (BRET) as previously described 307 (9). Briefly, HEK293 cells were transiently transfected with C5aR2-Venus and βarr2-Rluc8 constructs 308 using XTG9 (Roche). 24 hours post transfection, cells were gently detached using 0.05% trypsin-EDTA 309 and seeded (100,000/well) onto white 96-well TC plates (Corning) in phenol-red free DMEM containing 310 5% FBS. On the following day, cells were firstly incubated with the substrate EnduRen (30 µM, Promega) 311 for 2 hours (37 ℃, 5 % CO2). On a Tecan Spark 20M microplate reader (37℃), the BRET light emissions 312 (460-485 and 520-545 nm) were continuously monitored for 25 reads with respective ligands added 313 after the first 5 reads. The ligand-induced BRET ratio was calculated by subtracting the Venus (520-545 314 nm) over Rluc8 (460-485 nm) emission ratio of the vehicle-treated wells from that of the ligand-treated 315
wells. 316
Confocal Microscopy: For visualization of ligand-induced βarr recruitment, HEK293 cells were co-317 transfected with C5aR1 and βarr1-YFP or βarr2-YFP plasmids in 1:1 ratio (total 7μg) by PEI. 24 hour post-318 transfection, 1million cells were seeded in 35mm glass bottom dish pre-coated with 0.01% Poly-D-319
Lysine. After 24 hour, cells were serum starved for 6 hour and stimulated with respective doses of C5a 320 and C5a pep . For live-cell imaging, images were acquired using Carl Zeiss LSM780NLO confocal microscope 321 for specified time intervals and image processing was done in ZEN lite (Zen-blue/ ZEN-black) software 322 from Zeiss. 323
Intracellular calcium mobilization assays 324
Ligand-induced intracellular calcium mobilization was assessed using Fluo-4 NW Calcium Assay kit 325 (Thermo Fisher Scientific) following the manufacturer's instructions. Briefly, HMDMs were seeded 326 (50,000/well) in black clear-bottom 96-well TC plates (Corning) for 24 hours before the assay. Cells were 327 firstly stained with the Fluo-4 dye in assay buffer (1X HBSS, 20 mM HEPES) for 45 min (37 ℃, 5 % CO 2 ). 328
Respective ligands were prepared in assay buffer containing 0.5 % BSA. On a Flexstation 3 platform, the 329 fluorescence (Ex/Em: 494/516 nm) was continually monitored for a total of 100 seconds with ligand 330 addition performed at 16 seconds. 331
Chemotaxis assays 332
Ligand-induced hPMN migration was assessed using 6.5 mm Transwell polycarbonate membrane inserts 333 with 3.0 μm pore (Corning) to create a modified Boyden chamber (28). Freshly isolated hPMNs were 334 seeded onto inserts (500,000/well) for 20 min (37 ℃, 5 % CO 2 ) in a HBSS-based migration buffer as 335 described in previous section. To initiate cell migration, respective ligands prepared in migration buffer 336 were added to the receiver wells in duplicates. After 60-min migration (37 ℃, 5 % CO 2 ), the inserts were 337 gently washed once with DPBS, and the residual cells on the upper side of the membrane were removed 338 using a cotton swab. Migrated cells were detached by adding 500 μl/well Accumax solution (Invitrogen) 339 to the receiver wells (10 min, room temperature) and then counted using a Bio-Rad TC20™ automated 340 cell counter. 341
Measurement of cytokines release using ELISA 342
The immunomodulatory effect of respective C5aR ligands on LPS-induced cytokine release was assessed 343 in primary human macrophages as previously described (29). HMDMs were seeded in 96-well TC plates 344 (100,000 /well) for 24 hours before treatment. All ligands were prepared in serum-free IMDM 345 containing 0.1% BSA. For stimulation, cells were co-treated with LPS and respective C5aR ligands for 24 346 hours (37 ℃, 5 % C0 2 ). The supernatant was collected and stored at -20 ℃ till use. IL-6 levels in the 347 supernatant were quantified using respective human enzyme-linked immunosorbent assay (ELISA) kits 348 (BD OptEIA) as per the manufacturer's protocol. 349
Data collection, processing and analysis 350
All experiments were conducted in triplicate and repeated on at least 3 separate days (for cell lines) or 351 using cells from at least 3 donors (for HMDMs) unless otherwise specified. Data was analyzed using 352 were stimulated with respective ligands added to the receiver wells and then allowed to migrate for 1h. 547
The number of migrated cells was recorded and normalized to the maximal C5a-induced migration. Data 548 represents mean ± SEM of triplicate measurements conducted in cells from 3 independent donors. D. 549
The correlation plot between the LPA-induced IL-6 release and PMN migration reveals bias induced by 550 Figure S4 . C5a Pep induces sub-maximal ERK1/2 phosphorylation in HMDMs. HMDMs were serum starved overnight followed by incubation with respective ligands for 10min at room-temperature. Cells were lysed using AlphaLISA lysis buffer. For detection of phosphor-ERK1/2, cell lysate was added to donor and acceptor reaction mix and incubated at room temperature for 2hour.On a Tecan Spark 20M, following laser irradiation of donor beads at 680 nm, the chemiluminiscence of acceptor beads at 615 nm was recorded. 
